Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System

被引:1
作者
Agovi, Afiba Manza-A [1 ,2 ]
Anikpo, Ifedioranma [1 ]
Cvitanovich, Matthew J. [1 ]
Fasanmi, Esther O. [3 ,4 ]
Ojha, Rohit P. [1 ,2 ]
Marcus, Julia L. [5 ,6 ]
机构
[1] JPS Hlth Network, Ctr Epidemiol & Healthcare Delivery Res, Ft Worth, TX 76104 USA
[2] TCU & UNTHSC Sch Med, Dept Med Educ, Ft Worth, TX 76107 USA
[3] JPS Hlth Network, Pharm Clin Serv Outpatient, Ft Worth, TX USA
[4] JPS Hlth Network, Healing Wings Infect Dis Clin, Ft Worth, TX USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
关键词
HIV; prevention; pre-exposure prophylaxis; implementation; safety net; UNITED-STATES; MEDICAL HOME; CARE; IMPLEMENTATION;
D O I
10.1097/QAI.0000000000002767
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Safety-net health systems are key settings for HIV pre-exposure prophylaxis (PrEP) implementation, but little evidence is available about the frequency of PrEP prescribing in safety-net settings. We assessed PrEP prescribing among people with indications for PrEP at an urban safety-net health system that serves a county designated as an Ending the HIV Epidemic priority jurisdiction. Methods: We identified adults (aged 18 years or older) who engaged in primary care between January 2015 and December 2019 and had a documented indication for PrEP. PrEP indications included the presence of a behavioral or sexual risk factor of HIV acquisition or a positive bacterial sexually transmitted infection at the index visit. PrEP prescribing was defined as the proportion of patients with indications for PrEP who received a new prescription for PrEP. We estimated the cumulative incidence of PrEP prescription with corresponding 95% confidence limits (CL). Results: Our study population comprised 2957 individuals, of whom 58% was aged younger than 45 years, 56% was women, 67% was racial or ethnic minorities, and 60% was uninsured or provided care as part of a hospital-based managed care plan for individuals without insurance. We identified 41 individuals who were prescribed PrEP. The cumulative incidence of PrEP prescribing within 1 year of the first documented PrEP indication was 1.3% (95% CL: 0.91% to 1.7%). Conclusions: Our results suggest extremely low frequency of PrEP prescribing among people with indications for PrEP in an urban safety-net health system. Strategies are needed to improve PrEP implementation in high-priority populations and safety-net settings.
引用
收藏
页码:E17 / E21
页数:5
相关论文
共 50 条
  • [21] Next-Wave HIV Pre-Exposure Prophylaxis Implementation for Gay and Bisexual Men
    Golub, Sarit A.
    Myers, Julie E.
    AIDS PATIENT CARE AND STDS, 2019, 33 (06) : 253 - 261
  • [22] A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
    Siegler, Aaron J.
    Steehler, Kevin
    Sales, Jessica M.
    Krakower, Douglas S.
    CURRENT HIV/AIDS REPORTS, 2020, 17 (06) : 643 - 653
  • [23] Implementation of an HIV Pre-exposure Prophylaxis Strategy Into Abortion and Early Pregnancy Loss Care
    Sonalkar, Sarita
    McAllister, Arden
    Kete, Corinne
    Fishman, Jessica
    Frarey, Alhambra
    Short, William R.
    Schreiber, Courtney A.
    Teitelman, Anne
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 90 : S129 - S133
  • [24] Getting to Implementation for HIV Pre-Exposure Prophylaxis (GTI-PrEP): A data-driven approach to PrEP prescribing
    Shari S. Rogal
    Brittney Neely
    Monica Merante
    Karen Slazinski
    Lorenzo McFarland
    Christina Brodkorb
    Jada Cooper
    Carolyn Lamorte
    Sandra Gibson
    Emily Comstock
    Jamie Morano
    Marissa Maier
    Lauren A. Beste
    Karine Rozenberg
    Maggie Chartier
    Matthew J. Chinman
    David Ross
    Vera Yakovchenko
    Implementation Science Communications, 6 (1):
  • [25] HIV pre-exposure prophylaxis: the primary care implications of prescribing restrictions
    Wereski, Ryan
    BRITISH JOURNAL OF GENERAL PRACTICE, 2017, 67 (660) : 324 - 325
  • [26] Prescribing HIV pre-exposure prophylaxis: A qualitative analysis of health care provider training needs
    Bleasdale, Jacob
    Wilson, Kennethea
    Aidoo-Frimpong, Gloria
    Przybyla, Sarahmona
    JOURNAL OF HIV-AIDS & SOCIAL SERVICES, 2020, 19 (01) : 107 - 123
  • [27] Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention
    Rowan, Sarah E.
    Patel, Rupa R.
    Schneider, John A.
    Smith, Dawn K.
    LANCET HIV, 2021, 8 (02): : E114 - E120
  • [28] Psychiatry and Family Medicine Residents' Likelihood of Prescribing HIV Pre-exposure Prophylaxis to Patients With Mental Illness and HIV Vulnerability
    Bunting, Samuel R.
    Feinstein, Brian A.
    Vidyasagar, Nitin
    Sheth, Neeral K.
    Yu, Roger
    Hazra, Aniruddha
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 96 (03) : 231 - 240
  • [29] Pharmacists as providers of HIV pre-exposure prophylaxis
    Christine Bruno
    Parya Saberi
    International Journal of Clinical Pharmacy, 2012, 34 : 803 - 806
  • [30] Effectiveness of an electronic health record model for HIV pre-exposure prophylaxis
    Keizur, Erin
    Robinson, Eileen
    Sha, Beverly E.
    Aziz, Mariam
    Shankaran, Shivanjali
    INTERNATIONAL JOURNAL OF STD & AIDS, 2022, 33 (05) : 499 - 502